A Study of the Effect of LY2216684 on Lorazepam

• Status: Completed
• Trial end date: 2011-02-01

Summary

The purpose of this study is to determine how much lorazepam gets into the blood and how long it takes the body to get rid of it when given together with LY2216684. Information about any side effects that may occur will also be collected.

• Phase: Phase 1

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Lorazepam; Phenylethyl Alcohol